Облигации BMY
Ниже вы найдёте список корпоративных облигаций BRISTOL-MYERS SQUIBB CO. Инвесторы часто выбирают облигации компаний за их повышенную стабильность в периоды волнений на рынках. Изучите цены, доходность и другие данные, чтобы найти подходящие инвестиции.
Инструмент | Доходность к погашению % | Объём | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
---|---|---|---|---|---|---|---|---|---|
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 7,51% | 60 K | 79,78% | 5,00% | 2045-08-15 | 15,71 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
7,47% | 0 | 56,77% | 2,55% | 2050-11-13 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 7,17% | 152 K | 75,68% | 4,35% | 2047-11-15 | 13,57 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,88% | 0 | 65,93% | 2,35% | 2040-11-13 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,80% | 0 | 69,50% | 3,90% | 2062-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,73% | 0 | 71,00% | 3,70% | 2052-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,67% | 32 K | 72,54% | 3,25% | 2042-08-01 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 6,59% | 10 K | 93,18% | 5,70% | 2040-10-15 | 2,3 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,54% | 28,51 M | 78,40% | 4,25% | 2049-10-26 | 3,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,46% | 0 | 76,47% | 3,55% | 2042-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,44% | 393 K | 80,74% | 4,35% | 2047-11-15 | 1,24 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,40% | 65 K | 90,24% | 5,25% | 2043-08-15 | 4,06 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,38% | 20 K | 84,86% | 4,63% | 2044-05-15 | 3,69 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,37% | 5,61 M | 83,08% | 4,55% | 2048-02-20 | 1,24 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,27% | 174 K | 85,73% | 4,63% | 2044-05-15 | 744,72 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,21% | 1,96 M | 91,79% | 5,25% | 2043-08-15 | 218,37 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6,19% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,2 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,19% | 30 K | 109,00% | 6,88% | 2097-08-01 | 62,42 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. | |
6,16% | 0 | 94,11% | 5,65% | 2064-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,13% | 0 | 85,76% | 4,50% | 2044-03-01 | 341,52 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,05% | 0 | 94,76% | 5,55% | 2054-02-22 | 2,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,99% | 40 K | 90,93% | 5,00% | 2045-08-15 | 741,72 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,94% | 0 | 105,41% | 6,40% | 2063-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,93% | 20 K | 98,14% | 5,70% | 2040-10-15 | 151,01 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,88% | 0 | 96,62% | 5,50% | 2044-02-22 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,85% | 0 | 104,30% | 6,25% | 2053-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,71% | 6,77 M | 87,62% | 4,13% | 2039-06-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,37% | 0 | 103,61% | 5,88% | 2036-11-15 | 279,22 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5,27% | 10 K | 95,89% | 3,45% | 2027-11-15 | 16,55 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
5,26% | 0 | 99,63% | 5,20% | 2034-02-22 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,26% | 30 K | 106,69% | 6,13% | 2038-05-01 | 219,25 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,16% | 0 | 88,77% | 2,95% | 2032-03-15 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,98% | 0 | 105,52% | 5,90% | 2033-11-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,97% | 4,79 M | 84,67% | 1,45% | 2030-11-13 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,64% | 1,3 M | 95,57% | 3,40% | 2029-07-26 | 2,37 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,64% | 0 | 102,11% | 5,10% | 2031-02-22 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,60% | 750 K | 95,71% | 3,40% | 2029-07-26 | 26,56 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4,59% | 20 K | 98,26% | 3,90% | 2028-02-20 | 43,84 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
4,59% | 0 | 105,31% | 5,75% | 2031-02-01 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,52% | 26 K | 99,80% | 3,88% | 2025-08-15 | 228,73 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,50% | 168 K | 103,36% | 6,80% | 2026-11-15 | 255,95 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. | |
4,47% | 69 K | 100,30% | 4,85% | 2026-02-20 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,47% | 0 | 101,42% | 4,90% | 2029-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,44% | 0 | 97,97% | 3,25% | 2027-02-27 | 512,28 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,42% | 0 | 100,42% | 4,95% | 2026-02-20 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,41% | 776 K | 98,00% | 0,75% | 2025-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,37% | 0 | 92,53% | 1,13% | 2027-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,35% | 675 K | 98,74% | 3,20% | 2026-06-15 | 1,74 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,32% | 364 K | 98,00% | 3,45% | 2027-11-15 | 517,67 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,20% | 0 | 101,19% | 4,90% | 2027-02-22 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,15% | 6,73 M | 99,36% | 3,90% | 2028-02-20 | 1,45 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
3,54% | 0 | 86,70% | 1,75% | 2035-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. | |
2,57% | 0 | 99,91% | 1,00% | 2025-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. | |
2,47% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,39% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,35% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,32% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,27% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,95 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,47% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,28% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |